CAPITAL STOCK AND (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
|
|
|
|
Jun. 19, 2026 |
Jun. 04, 2026 |
May 29, 2026 |
Apr. 28, 2026 |
Apr. 27, 2026 |
Mar. 30, 2026 |
Mar. 13, 2026 |
Feb. 06, 2026 |
Feb. 03, 2026 |
Oct. 31, 2025 |
Mar. 06, 2025 |
May 31, 2026 |
Apr. 30, 2026 |
Feb. 28, 2026 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jan. 01, 2026 |
Dec. 31, 2025 |
Jul. 03, 2024 |
Feb. 15, 2022 |
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
|
$ 0.001
|
|
|
| Preferred stock,shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
5,000,000
|
|
|
5,000,000
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
0
|
|
|
0
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
|
$ 0.001
|
|
$ 0.001
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000,000
|
|
500,000,000
|
|
|
500,000,000
|
|
500,000,000
|
| Warrants to purchase, share exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,748,971
|
|
|
|
|
|
| Warrants to purchase shares |
657,876
|
|
100,000
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
1,257,876
|
|
|
|
|
|
| Warrants forefeiture |
|
|
|
|
|
|
|
|
|
|
|
|
|
226,029
|
|
|
226,029
|
|
|
|
|
|
| Conversion of shares |
|
|
|
|
|
|
|
19,223
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion of value |
|
|
|
|
|
|
|
$ 8,579
|
|
|
|
|
|
|
|
$ 8,579
|
|
|
|
|
|
|
| Restricted stock units vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,574
|
|
|
|
|
|
| Restricted common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
249,000
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.00
|
|
$ 5.00
|
|
|
|
|
|
| Restricted common stock shares issued value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,245,000
|
|
|
|
|
|
|
|
| Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,051,824
|
|
13,051,824
|
|
|
9,785,056
|
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,051,824
|
|
13,051,824
|
|
|
9,785,056
|
|
|
| Stock based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 981,455
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,495,000
|
$ 650,000
|
|
|
|
|
|
|
| Weighted-average remaining term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years 6 months 25 days
|
|
|
|
|
|
| Exercise price |
$ 5.00
|
|
$ 5.00
|
|
$ 5.00
|
|
|
|
|
$ 5.50
|
$ 1.70
|
|
|
|
|
|
|
|
|
|
$ 0.397
|
|
| Warrants expire |
Jun. 19, 2028
|
|
|
|
Apr. 26, 2031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
The warrants may be exercised only on
a cash basis and include a 4.999% beneficial ownership limitation, which may be increased to 9.999% by a holder upon at least 61 days’
prior written notice to the Company.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,075,592
|
$ 1,724,064
|
|
|
|
|
| Warrants issued in acquisition of intangibles |
|
$ 1,743,829
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,743,829
|
|
|
|
|
|
| Aggregate grant date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,548,508
|
|
|
|
|
|
| Aggregate number of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,500,000
|
|
1,500,000
|
|
|
|
|
|
| Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares unvested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
300,000
|
|
|
|
|
|
| Stock based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 80,799
|
|
|
|
|
|
| Employee service share based compensation nonvested awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,344,201
|
|
$ 1,344,201
|
|
|
|
|
|
| Aggregate grant date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
|
|
300,000
|
|
|
|
|
|
| Nonvested award, cost not yet recognized, period for recognition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years 6 months 3 days
|
|
|
|
|
|
| Darren Cahill [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
250,000
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
$ 5.00
|
|
|
|
|
|
|
|
|
$ 1.70
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expire |
|
Jun. 04, 2031
|
|
|
|
|
|
|
|
|
Mar. 05, 2030
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
The warrants are exercisable as
to one half of the shares of common stock immediately, and exercisable as to the remaining half of the shares of common stock one year
following the grant date of the warrants.
|
|
|
|
|
|
|
|
|
The warrants are exercisable as to one half of the shares of common stock immediately, and exercisable as to the remaining half
of the shares of common stock one year following the grant date of the warrants
|
|
|
|
|
|
|
|
|
|
|
|
| George Mackin [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expire |
|
|
|
|
|
|
|
|
Feb. 02, 2029
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
The warrants are exercisable as to one half of the shares of common stock immediately, and exercisable as to the remaining half
of the shares of common stock one year following the grant date of the warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Justin Gimblestob [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
$ 1.70
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expire |
|
|
|
|
|
|
|
|
|
|
Mar. 05, 2030
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
|
|
The warrants are exercisable as to one half of the shares of common stock immediately, and exercisable as to the remaining half of the
shares of common stock one year following the grant date of the warrants
|
|
|
|
|
|
|
|
|
|
|
|
| Trademark Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.75
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The warrants include a 4.999% beneficial ownership limitation, which can be
increased to 9.999% by either holder, with at least 61 days prior written notice to the Company.
|
|
|
|
|
|
| Stefanie Graf [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
$ 5.50
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
|
The warrants expire on October 31, 2030. The warrants are exercisable
as to one half of the shares of common stock immediately, and exercisable as to the remaining half of the shares of common stock one
year following the grant date of the warrants.
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock Awards [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
|
|
$ 5.50
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
|
|
|
|
60,000
|
|
|
|
|
|
|
|
|
|
|
| Share issued value |
|
|
|
|
|
|
|
|
|
|
|
$ 330,000
|
|
|
|
|
|
|
|
|
|
|
| Share vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
20,000
|
|
|
|
|
|
| Shares unvested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
40,000
|
|
|
|
|
|
| Stock based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 110,000
|
|
$ 110,000
|
|
|
|
|
|
| Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 4.70
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
|
|
|
|
|
9,574
|
|
|
|
|
|
|
|
|
|
| Share vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,574
|
|
69,574
|
|
|
|
|
|
| Shares unvested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
40,000
|
|
|
|
|
|
| Stock based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 45,000
|
|
$ 45,000
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,000
|
|
|
|
|
|
| Allocated share based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
155,000
|
|
155,000
|
|
|
|
|
|
| Employee service share based compensation nonvested awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 220,000
|
|
$ 220,000
|
|
|
|
|
|
| Investments AKA, LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase, share exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
705,417
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
651,231
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
299,000
|
|
|
|
|
|
|
|
| Share issued value |
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceed of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,495,000
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted common stock shares issued |
|
|
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
$ 5.00
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted common stock shares issued value |
|
|
|
|
|
$ 250,000
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investor [Member] | Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted common stock shares issued |
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Boreta Lifetime Trust [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
| Share issued value |
|
|
|
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 250,000
|
|
|
|
|
|
| James Askew [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase, share exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,269,583
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,097,740
|
|
|
|
|
|
|
|
|
| Chief Financial Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
$ 1.70
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expire |
|
|
|
|
|
|
|
|
|
|
Mar. 05, 2030
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
|
|
The warrants are exercisable as to one half of the shares of common stock immediately, and exercisable
as to the remaining half of the shares of common stock one year following the grant date of the warrants.
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise of warrants, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,748,971
|
|
2,748,971
|
|
|
|
|
|
|
| Conversion of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,223
|
|
|
|
|
|
|
| Conversion of value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 19
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
299,000
|
130,000
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 299
|
$ 130
|
|
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
$ 1,743,829
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 801,798
|
|
|
|
|
|